MDXG
Income statement / Annual
Last year (2024), MiMedx Group, Inc.'s total revenue was $348.88 M,
an increase of 8.52% from the previous year.
In 2024, MiMedx Group, Inc.'s net income was $42.42 M.
See MiMedx Group, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$348.88 M |
$321.48 M |
$267.84 M |
$258.62 M |
$248.23 M |
$299.26 M |
$359.11 M |
$321.14 M |
$245.02 M |
$187.30 M |
Cost of Revenue |
$60.07 M
|
$54.63 M
|
$48.32 M
|
$43.28 M
|
$39.33 M
|
$43.08 M
|
$36.39 M
|
$35.22 M
|
$32.41 M
|
$20.20 M
|
Gross Profit |
$288.81 M
|
$266.84 M
|
$219.53 M
|
$215.33 M
|
$208.90 M
|
$256.17 M
|
$322.73 M
|
$285.92 M
|
$212.61 M
|
$167.09 M
|
Gross Profit Ratio |
0.83
|
0.83
|
0.82
|
0.83
|
0.84
|
0.86
|
0.9
|
0.89
|
0.87
|
0.89
|
Research and Development Expenses |
$12.34 M
|
$12.67 M
|
$22.83 M
|
$17.34 M
|
$11.72 M
|
$11.14 M
|
$15.77 M
|
$17.90 M
|
$12.04 M
|
$8.41 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$225.09 M
|
$211.12 M
|
$208.79 M
|
$198.36 M
|
$181.02 M
|
$198.21 M
|
$258.53 M
|
$220.12 M
|
$180.00 M
|
$133.38 M
|
Other Expenses |
-$7.49 M
|
$5.94 M
|
$12.88 M
|
$4.61 M
|
$60.54 M
|
$67.54 M
|
$527,000.00
|
-$87,000.00
|
$2.13 M
|
$933,000.00
|
Operating Expenses |
$229.94 M
|
$229.73 M
|
$244.50 M
|
$220.31 M
|
$253.28 M
|
$276.89 M
|
$326.65 M
|
$239.70 M
|
$194.16 M
|
$142.73 M
|
Cost And Expenses |
$290.01 M
|
$284.36 M
|
$292.81 M
|
$263.60 M
|
$292.61 M
|
$319.97 M
|
$363.04 M
|
$274.92 M
|
$226.57 M
|
$162.93 M
|
Interest Income |
$0.00
|
$0.00
|
$5.02 M
|
$4.98 M
|
$7.94 M
|
$4.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$1.01 M
|
$6.46 M
|
$5.02 M
|
$4.98 M
|
$7.94 M
|
$4.71 M
|
$0.00
|
$0.00
|
$339,000.00
|
$86,000.00
|
Depreciation & Amortization |
$6.04 M
|
$3.43 M
|
$4.05 M
|
$6.17 M
|
$7.84 M
|
$8.53 M
|
$6.92 M
|
$5.77 M
|
$5.46 M
|
$2.73 M
|
EBITDA |
$64.34 M |
$40.52 M |
-$10.69 M |
-$1.89 M |
-$45.76 M |
-$12.35 M |
$2.99 M |
$53.04 M |
$23.91 M |
$27.10 M |
EBITDA Ratio |
0.18
|
0.13
|
-0.08
|
0
|
-0.15
|
-0.04
|
0.01
|
0.17
|
0.1
|
0.14
|
Operating Income Ratio |
0.17
|
0.12
|
-0.09
|
-0.02
|
-0.18
|
-0.07
|
-0.01
|
0.14
|
0.08
|
0.13
|
Total Other Income/Expenses Net |
-$1.57 M
|
-$6.48 M
|
-$5.02 M
|
-$2.99 M
|
-$16.15 M
|
-$4.43 M
|
$527,000.00
|
-$1.14 M
|
-$339,000.00
|
-$86,000.00
|
Income Before Tax |
$57.29 M
|
$30.63 M
|
-$29.99 M
|
-$10.04 M
|
-$61.54 M
|
-$25.59 M
|
-$3.40 M
|
$45.09 M
|
$18.11 M
|
$24.28 M
|
Income Before Tax Ratio |
0.16
|
0.1
|
-0.11
|
-0.04
|
-0.25
|
-0.09
|
-0.01
|
0.14
|
0.07
|
0.13
|
Income Tax Expense |
$15.30 M
|
-$36.81 M
|
$206,000.00
|
$247,000.00
|
-$12.26 M
|
-$5,000.00
|
$26.58 M
|
-$19.64 M
|
$6.13 M
|
-$5.17 M
|
Net Income |
$42.42 M
|
$67.44 M
|
-$30.20 M
|
-$10.29 M
|
-$49.28 M
|
-$25.58 M
|
-$29.98 M
|
$64.73 M
|
$11.97 M
|
$29.45 M
|
Net Income Ratio |
0.12
|
0.21
|
-0.11
|
-0.04
|
-0.2
|
-0.09
|
-0.08
|
0.2
|
0.05
|
0.16
|
EPS |
0.29 |
0.48 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.61 |
0.0037 |
0.28 |
EPS Diluted |
0.28 |
0.38 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.56 |
0.0035 |
0.26 |
Weighted Average Shares Out |
$146.98 M
|
$116.50 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$106.12 M
|
$105.93 M
|
$105.93 M
|
Weighted Average Shares Out Diluted |
$149.05 M
|
$145.96 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$116.11 M
|
$112.65 M
|
$113.63 M
|
Link |
|
|
|
|
|
|
|
|
|
|